FEVR (Inspire Faithward Large Cap Momentum ESG ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.


Fevertree Drinks (AIM:FEVR) has retained the backing of Jefferies, which kept its 'buy' recommendation and 1,100p price target after first-half results pointed to stronger US momentum and improving earnings prospects. The broker viewed the results as early evidence that of the Group's partnership with Molson Coors is beginning to deliver, with US revenue growth reaching 11% at constant currency and sales momentum building as distribution, merchandising and marketing activity expands.

Fevertree Drinks (AIM: FEVR) delivered stronger first-half earnings as US sales accelerated under its Molson Coors partnership and the UK business returned to growth. Adjusted Fever-Tree brand revenue increased 8% at constant currency to £183.6 million in the six months to 30 June, while adjusted EBITDA rose 9% to £20.1 million.

Fevertree Drinks (AIM:FEVR), the premium mixer brand, posted a 2% rise in full-year revenue to £375 million but saw profits slide due to initial costs from the first year of its US distribution partnership with Molson Coors and a new environmental levy. Adjusted EBITDA fell 16% to £42.4 million, as margins fell from 13.7% to 11.3%.

There was a fresh burst of life in Fevertree Drinks (AIM:FEVR) share price after Jefferies upgraded the premium mixer maker to 'buy' from 'hold', sending the shares up 4.5% to 822p. The investment bank also raised its target price to £11, implying more than 35% upside, arguing that the company's new partnership in the United States with Molson Coors marks a “transformational” moment.

Fevertree Drinks (AIM:FEVR) reported interim results in line with expectations and said it remained confident in the full-year outlook. Revenue was stable at £172.2 million, up 2% at constant currency.

Fevertree Drinks (AIM:FEVR) shares jumped 6% on Tuesday morning after the premium mixer maker reiterated its full-year guidance and struck an upbeat tone on the medium-term benefits of its new partnership with Molson Coors in the United States. The London-listed drinks brand said it expected continued revenue and profit growth in 2025, despite a transition year as the US business shifts under the new agreement.

Fevertree Drinks (AIM:FEVR) has been downgraded by Deutsche Bank, where analysts say the Molson Coors deal "lacks near-term fizz". Shares in the mixers maker fell 1.5% today as the bank cut its rating to 'hold' from 'buy', and its target price to 800p from 1325p.

Fevertree Drinks (AIM:FEVR) plc, the maker of the premium range of drinks mixers, has been given a lower share price target by Deutsche Bank after failing to make a splash in last-week's first-half results. Though sales were up 10% in the US (which became the largest geographic market last year), they were down 6% in the UK and 10% in Europe.